Putting the safety of moms-to-be first, when it comes to IVF

Priya Kannan· Jul 25, 2026 · 7:30 AM UTC ·4 min read · 0 reactions · 0 comments · 13 views

TL;DR · WeSearch summary

In vitro fertilisation (IVF) is regulated in India by the ART Act 2021 and typically uses a stimulated cycle to increase egg yield. Safety concerns, particularly ovarian hyperstimulation syndrome (OHSS), are central to current practice guidelines. Clinics are adopting protocols such as GnRH antagonist stimulation, GnRH agonist triggering, and a freeze‑all strategy to minimise OHSS risk and improve outcomes.

Key facts

▪IVF involves ovarian stimulation, egg retrieval, fertilisation, embryo culture, and transfer, with options to freeze gametes and embryos for later use.
▪OHSS, a potentially life‑threatening complication, occurs in an estimated 2‑8% of cycles as moderate cases and about 0.1% as severe cases.
▪Risk factors for OHSS include younger age, PCOS, high estradiol levels, and the number of follicles stimulated.
▪Adopting a segmentation approach—short GnRH antagonist protocols, GnRH agonist triggers, and freeze‑all embryo transfers—has been shown to reduce OHSS incidence.

About this source

The Hindu publishes from India and files mainly under world. We currently carry 1,042 of its stories.

All The Hindu coverage →

Original article

The Hindu · Priya Kannan

Read full at The Hindu →

Story provenance

Source · retrieval · rights · ranking — open for full record

inspect →

Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.

Record

Original publisher	The Hindu
Canonical URL	https://www.thehindu.com/sci-tech/health/putting-the-safety-of-moms-to-be-first-when-it-comes-to-ivf/article71260868.ece
Publication time	Sat, 25 Jul 2026 13:00:00 +0530
Retrieval time	2026-07-25T07:42:07.288Z
Last seen	2026-07-25T07:42:07.288Z
Headline source	Publisher (no WeSearch rewrite)
Excerpt source	publisher body
Excerpt method	First ~120 words (~800 chars) of extracted publisher body, fair-use limited.
Summary	WeSearch · cerebras-chat (WeSearch summarizer)
Summary source text	contentText
Citation coverage	Summary is a WeSearch-generated derivative; primary citation is the original publisher URL.
Cluster	YEL-xSSe57Lf
Cluster logic	Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison.
Ranking reason	Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking.
Publisher visit	Yes — open original
Substitutes article?	No — link-out required for full text

Rights status (four layers)

Publisher-declared

No publisher-confirmed rights record for this source yet.

Machine-readable

No source-specific machine-readable restriction detected beyond the public feed.

WeSearch interpretation

WeSearch declared handling (basis: Derived from the published RSS/Atom feed). This is WeSearch policy, not a legal grant on the publisher's behalf.

Unknown

Retrieval and training permissions are not asserted unless the publisher confirms them.

WeSearch handling by dimension

Indexing	May the item be indexed (stored, ranked, made findable)?	Allowed
Snippet	May a short excerpt of the publisher's text be shown?	Allowed
AI summary	May WeSearch generate its own short summary of the article?	Limited
Retrieval / RAG	May the content be exposed for third-party retrieval-augmented generation?	Not asserted
Model training	May the content be used to train AI models?	Not asserted
Commercial reuse	May the content be reused commercially?	Not permitted

Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.

Open original publisher → Source rights JSON → Machine-readable provenance → Rights framework → WESEARCH-STORY-PROVENANCE-V1

Opening excerpt (first ~120 words) tap to expand

In vitro Fertilisation (IVF), colloquially known as ‘test tube babies’ remains one of the most efficacious methods of fertility treatment; its success, however, depends on many factors – approximately 200 variables. Presently, all interventional fertility treatments such as Intra Uterine Insemination (IUI), IVF, Intra Cytoplasmic Sperm Injection (ICSI) and all the allied procedures such as egg, sperm and embryo freezing and Pre-implantation Genetic Testing (PGT) among others are encompassed as Assistive Reproductive Techniques (ART), regulated in our country by the ART Act, 2021. IVF is expensive.

…

Excerpt limited to ~120 words for fair-use compliance. The full article is at The Hindu.

Anonymous · no account needed

Discussion

0 comments